TMOライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (4 5月 2024 @ 05:00):

Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide...

Stats
本日の出来高	1.75M
平均出来高	1.34M
時価総額	218.49B
EPS	$0 ( 2024-04-24 )
次の収益日	( $5.13 ) 2024-07-24
Last Dividend	$0.350 ( 2023-12-14 )
Next Dividend	$0 ( N/A )
P/E	36.76
ATR14	$0.280 (0.05%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Casper Marc N	Buy	10 000	Common Stock
2024-05-01	Casper Marc N	Sell	378	Common Stock
2024-05-01	Casper Marc N	Sell	1 400	Common Stock
2024-05-01	Casper Marc N	Sell	2 100	Common Stock
2024-05-01	Casper Marc N	Sell	1 145	Common Stock

INSIDER POWER
-62.75
Last 98 transactions
Buy: 76 634 \| Sell: 328 022

ボリューム相関

長: -0.65 (weak negative)

短: -0.25 (neutral)

Signal:(30.039) Neutral

Thermo Fisher Scientific 相関

10 最も正の相関
GOEX	0.806
NUGT	0.806
GDXJ	0.805
SGDJ	0.801

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Thermo Fisher Scientific 相関 - 通貨/商品

0.64
( weak )

0.29
( neutral )

0.49
( neutral )

0.51
( weak )

-0.21
( neutral )

-0.04
( neutral )

Thermo Fisher Scientific 財務諸表

Annual	2023
収益:	$42.86B
総利益:	$15.22B (35.52 %)
EPS:	$15.53

FY	2023
収益:	$42.86B
総利益:	$15.22B (35.52 %)
EPS:	$15.53

FY	2022
収益:	$44.92B
総利益:	$19.50B (43.42 %)
EPS:	$17.73

FY	2021
収益:	$39.21B
総利益:	$19.64B (50.08 %)
EPS:	$19.62

Financial Reports:

No articles found.

Thermo Fisher Scientific Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.300 (N/A)	$0.300 (N/A)	$0.350 (N/A)	$0.350 (N/A)	$0.350 (N/A)	$0.350 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Thermo Fisher Scientific Dividend Information - Dividend Knight

Dividend Sustainability Score: 9.13 - good (91.31%) | Divividend Growth Potential Score: 6.05 - Stable (20.96%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0430	1993-08-06
Last Dividend	$0.350	2023-12-14
Next Dividend	$0	N/A
Payout Date	2024-01-16
Next Payout Date	N/A
# dividends	52	--
Total Paid Out	$12.89	--
Avg. Dividend % Per Year	0.15%	--
Score	4.36	--
Div. Sustainability Score	9.13
Div.Growth Potential Score	6.05
Div. Directional Score	7.59	--

Next Divdend (Est)
(2024-07-05)

$0.358 Estimate 34.05 %

Dividend Stability

0.68 Above Average

Dividend Score

4.36

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1993	$0.0430	0.31%
1994	$0	0.00%
1995	$0	0.00%
1996	$0.00400	0.01%
1997	$0	0.00%
1998	$0	0.00%
1999	$0	0.00%
2000	$0	0.00%
2001	$3.34	11.50%
2002	$0	0.00%
2003	$0	0.00%
2004	$0	0.00%
2005	$0	0.00%
2006	$0	0.00%
2007	$0	0.00%
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0.540	1.15%
2013	$0.600	0.92%
2014	$0.600	0.55%
2015	$0.600	0.47%
2016	$0.600	0.43%
2017	$0.600	0.42%
2018	$0.680	0.35%
2019	$0.760	0.35%
2020	$0.880	0.27%
2021	$1.040	0.22%
2022	$1.200	0.19%
2023	$1.400	0.25%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
SJT	Dividend Royal	2023-11-29	Monthly	39	12.52%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50
ORC	Dividend Royal	2023-11-29	Monthly	12	9.23%	8.50
SRV	Dividend Royal	2023-12-04	Monthly	18	7.53%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.142	1.500	7.16	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0621	1.200	7.93	9.51	[0 - 0.3]
returnOnEquityTTM	0.133	1.500	9.63	10.00	[0.1 - 1]
payoutRatioTTM	0.0897	-1.000	9.10	-9.10	[0 - 1]
currentRatioTTM	1.696	0.800	6.52	5.22	[1 - 3]
quickRatioTTM	1.192	0.800	7.70	6.16	[0.8 - 2.5]
cashRatioTTM	0.395	1.500	8.92	10.00	[0.2 - 2]
debtRatioTTM	0.367	-1.500	3.89	-5.83	[0 - 0.6]
interestCoverageTTM	-103.18	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	23.37	2.00	2.21	4.42	[0 - 30]
freeCashFlowPerShareTTM	19.79	2.00	0.105	0.209	[0 - 20]
debtEquityRatioTTM	0.782	-1.500	6.87	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.412	1.000	6.47	6.47	[0.2 - 0.8]
operatingProfitMarginTTM	0.165	1.000	8.70	8.70	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.251	1.000	9.72	9.72	[0.2 - 2]
assetTurnoverTTM	0.438	0.800	-0.416	-0.333	[0.5 - 2]
Total Score				9.13

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	36.24	1.000	6.44	0	[1 - 100]
returnOnEquityTTM	0.133	2.50	9.76	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	19.79	2.00	3.40	0.209	[0 - 30]
dividendYielPercentageTTM	0.252	1.500	3.71	0	[0 - 0.4]
operatingCashFlowPerShareTTM	23.37	2.00	2.21	4.42	[0 - 30]
payoutRatioTTM	0.0897	1.500	9.10	-9.10	[0 - 1]
pegRatioTTM	11.24	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.210	1.000	7.25	0	[0.1 - 0.5]
Total Score				6.05

Thermo Fisher Scientific

Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.